RE: New oncology Affimer paper out of Leeds6 Jun 2020 09:51
A couple of snippets in plain English I liked...
‘could revolutionise drug discovery, exemplifying a novel pipeline for small molecule design that has the potential to unlock the vast number of currently ‘undruggable’ proteins.’
‘ The approach utilised in this study is likely to be applicable to other important therapeutic targets, and provides a novel pipeline for drug discovery.’
In a nutshell, affimers are disruptive tech, the small size means they can not only replace antibodies but are far superior. I’m not surprised the paper included disclaimers that some of them own Awacta shares! Tomlinson lab are having a field day with affimers, great stuff. Another candidate for a lot of bumping on the chat all day today, absolutely incredible discoveries. Let’s get this Covid thing out of the way and get cancer sorted!